In addition, in order to achieve a plateau of efficacy (80% E max ), 2 g/day l-carnitine was required for at least 2 weeks
(EtherPC-1 n = 14 metabolites, EtherPC-2 n = 90 metabolites, EtherPE-1 n = 58 metabolites, EtherPE-2 n = 67 metabolites, FA-1 n = 15 metabolites, FA-2 n = 29 metabolites, PC-1 n = 62 metabolites, PC-2 n = 51 metabolites, PG-1 n = 55 metabolites, PG-2 n = 45 metabolites, TG-1 n = 10 metabolites, TG-2 n = 96 metabolites)
Strength, dose, route of administration, and other variables may make compounded medications different from FDA-approved drugs which makes directly comparing results & risk profile between FDA-approved drugs and compounded drugs difficult
What makes KLOW different from a single peptide
Is the common one that most of us [00:13:00] know